3rd Quarter 2024
ADVANCEMENT IN RESEARCH & DEVELOPMENT STUDIES
In-depth studies on the administration methods for the therapy are progressing. The results obtained confirm the efficacy of REMaST® in promoting motor recovery and tissue regeneration in animal models of spinal cord injury, even when using the intrathecal route of administration. The intrathecal approach has proven to be less invasive compared to the methods used so far, representing a significant step forward in the pursuit of safer and more practical treatments.
SCIENTIFIC PUBLICATION: A SIGNIFICANT STEP FORWARD
Hemera’s scientific work on the preclinical results of REMaST® is currently under review by a prestigious high-impact scientific journal. In the meantime, the publication is available as a preprint on the public portal bioRxiv at the following link: View the publication.